References
Referencesarepublicationsthatsupporttheproducts'biologicalactivity.
Brysonetal(1993)Cladribine.Areviewofitspharmacodynamicandpharmacokineticpropertiesandtherapeuticpotentialinhaematologicalmalignancies.Drugs46872PMID:7507037
Robaketal(2006)Olderandnewformulationsofcladribine.Pharmacologyandclinicalefficacyinhematologicalmalignancies.RecentPat.AnticancerDrugDiscov.123PMID:18221024
Setoetal(1985)Mechanismofdeoxyadenosineand2-chlorodeoxyadenosinetoxicitytonondividinghumanlymphocytes.J.Clin.Invest.75377PMID:2579098
Keywords:Cladribine,supplier,leukemia,adenosine,deaminase,antileukemic,proapoptotic,ribonuclease,reductase,deoxyadenosine,analogue,analog,2-Chloro-2-deoxyadenosine,antimetabolites,2-Chloro-2"-deoxyadenosine,Apoptosis,Inducers,Ribonucleotide,Reductase,Apoptosis,Inducers,TocrisBioscience